ReviewEmergency radiology2022
How low can we go? Strategies and recommendations to combat the iodinated contrast shortage.
Review in Emergency radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Shortage of iodinated contrast media: Status and possible chances - A systematic review.European journal of radiology · 2023Pooled it
- A global contrast shortage: a descriptive study exploring IV contrast utilization and outcomes in trauma patients at a level I trauma center.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026Article
- Feasibility of a single-phase portal venous CT protocol using bolus tracking technique and lean body weight-based contrast media dose.European radiology · 2025Article
- An adult and pediatric size-based contrast administration reduction phantom study for single and dual-energy CT through preservation of contrast-to-noise ratio.Journal of applied clinical medical physics · 2024Article
- Impact of iodinated contrast shortage on contrast-associated acute kidney injury: a single center experience.Proceedings (Baylor University. Medical Center) · 2024Article
- Updated estimates of large and medium vessel strokes, mechanical thrombectomy trends, and future projections indicate a relative flattening of the growth curve but highlight opportunities for expanding endovascular stroke care.Journal of neurointerventional surgery · 2023Article
- CT of the Larynx: Is an Additional High-Resolution Acquisition Necessary for Diagnostic Accuracy?AJNR. American journal of neuroradiology · 2023Article
- Strategies for calculating contrast media dose for chest CT.European radiology experimental · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
After GE Healthcare, one of the major producers of iodinated contrast dye, was forced to close their Shanghai factory due to a recent COVID-19 outbreak, iodinated contrast media shortages have rocked healthcare systems to their core. Clinicians nationwide are now caught between the desire to provide patients with optimal care and the need to conserve the minimal remaining supplies of iodinated contrast media. While GE Healthcare has reopened their factory and other sources of contrast agents have become available, experts report that levels may not return to normal through June 2022. Thankfully and ironically, radiology departments are all too familiar with COVID-19 associated operational disruptions and have been quick to adapt and implement novel protocols to evade this and other crises. Overall, this shortage emphasizes the importance of interprofessional communication, adaptation, and preparation for future emergent situations as this is not the first iodinated contrast material shortage and it likely would not be the last.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.